Terlipressin given as continuous intravenous infusion is the more suitable schedule for the treatment of type 1 hepatorenal syndrome (HRS) in patients with cirrhosis: results of a controlled clinical study

ANGELI, PAOLO;FASOLATO, SILVANO;Cavallin M.;Trotta A.;MARESIO, GIULIO;Callegaro A.;Galioto A.;MAZZA, ELENA;STICCA, ANTONIETTA;Benetti G. P.;GATTA, ANGELO

2008